Vyant Bio to Present at the Q4 Investor Summit Micro & Small Cap Conference

NEXT STORY
Arbutus Announces New Data on AB-729 in Late Breaker Poster Presentation at AASLD – The Liver Meeting®
PREV STORY
Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Omadacycline Concentrations Exceed Tigecycline Levels in Lungs and Epithelial Lining Fluid According to Pharmacokinetic/Pharmacodynamic (PK/PD) Data

VIENNA, Austria, April 25, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today presented ...

author_avatar
NASDAQ Market News

RedHill Biopharma Enrolls 400th Patient in Confirmatory Phase III Study with TALICIA® for H. pylori Infection

400 of the planned total of 444 patients have been enrolled in the ongoing ...

author_avatar
NASDAQ Market News

WishBone Medical, Inc. and Hospital for Special Surgery (HSS) Collaborate to Develop a Novel Pediatric Total Hip Implant.

NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc., a new global ...

author_avatar
NASDAQ Market News